Equities

Monash IVF Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Monash IVF Group Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.705
  • Today's Change0.005 / 0.71%
  • Shares traded641.59k
  • 1 Year change-40.00%
  • Beta0.7453
Data delayed at least 20 minutes, as of Feb 16 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Monash IVF Group Limited is a provider of Assisted Reproductive Services (ARS). It offers a range of techniques used to assist patients experiencing infertility in achieving a clinical pregnancy, including reproductive genetic services. It is also a provider of specialized women's imaging services. It provides a range of specialist diagnostic obstetric and gynecological ultrasound and fertility treatment. Its segments consist of two operations: Australia IVF and Ultrasound, providing ARS, ultrasound and other related services. International IVF, providing ARS in Southeast Asia. Its business includes fertility solutions that provide fertility treatment and care; KL Fertility is a fertility specialist center; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility center, and Monash Ultrasound for Women provides tertiary level prenatal diagnostic services. Its business also includes Repromed and Sydney Ultrasound for Women.

  • Revenue in AUD (TTM)271.92m
  • Net income in AUD25.01m
  • Incorporated2014
  • Employees892.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cryosite Ltd14.12m1.88m58.33m25.0031.6524.4221.174.130.03780.03780.28340.0490.7206102.477.87564,640.009.626.6612.298.0962.9860.8713.3511.831.95--0.4869--11.939.382.394.94-8.42--
Cleo Diagnostics Ltd1.18m-4.00m82.80m----13.32--69.89-0.0314-0.03140.00920.04540.1409--18.51---47.57---52.53-------337.54------0.00--97.41---6.38------
Apiam Animal Health Ltd206.92m832.00k145.62m--205.571.1710.690.70370.00380.00381.110.66130.8094.5715.75--0.33781.650.38961.9366.2263.460.41751.970.50262.330.458671.371.1111.83-83.13-27.2927.960.3129
Eureka Group Holdings Ltd45.79m20.06m200.49m42.009.280.82979.764.380.05060.05060.11890.56640.1506--206.26--6.606.126.756.2954.7652.7543.8137.02----0.190830.2211.3013.0451.9019.9021.256.71
Monash IVF Group Ltd271.92m25.01m272.74m892.0010.971.115.721.000.06380.06380.69470.63210.54333.439.15304,839.705.134.126.324.8489.1689.429.447.690.53216.080.418295.496.6513.34483.1516.3613.965.80
Australian Clinical Labs Ltd741.27m32.43m465.17m4.70k13.912.752.750.62750.1740.1743.900.88121.277.9010.16157,716.805.6212.058.8418.5382.7081.444.438.790.48264.880.62855.616.458.6135.50-4.70-2.16--
Artrya Ltd28.00k-16.41m490.06m----16.51--17,502.16-0.1782-0.17820.00030.18780.0013--0.006---76.86-50.54-84.04-53.79-----58,592.86-224,202.80----0.0285-------17.19--76.21--
Healius Ltd1.34bn-563.00m562.75m8.00k--0.9572--0.4187-0.7754-0.20821.850.80960.56486.947.21168,025.00-23.66-7.07-30.32-8.6784.0885.70-41.88-14.730.49780.00310.608--5.69-2.9015.97---7.13--
Australian Unity Ltd2.56bn29.28m577.79m7.70k----5.650.2256--------0.2504------0.28630.2535--------1.141.08--2.320.3517--19.2212.82225.8526.26-3.12--
Integral Diagnostics Ltd627.22m4.67m895.02m3.03k200.171.2914.591.430.0120.0122.021.860.577913.4923.69207,343.800.4440.37460.49590.420295.5295.190.76830.6680.65952.130.4574568.8933.7017.91107.70-27.3118.22-7.07
Data as of Feb 16 2026. Currency figures normalised to Monash IVF Group Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

32.06%Per cent of shares held by top holders
HolderShares% Held
Argo Investments Ltd. (Investment Management)as of 30 Sep 202524.38m6.26%
Tribeca Investment Partners Pty Ltd.as of 01 Feb 202524.10m6.19%
Lennox Capital Partners Pty Ltd.as of 10 Jun 202519.69m5.05%
Challenger Ltd. (Investment Management)as of 10 Jun 202519.69m5.05%
UniSuper Management Pty Ltd.as of 11 Apr 202517.10m4.39%
Regal Funds Management Pty Ltd.as of 21 Nov 20257.20m1.85%
Dimensional Fund Advisors LPas of 05 Feb 20266.19m1.59%
DFA Australia Ltd.as of 31 Dec 20254.17m1.07%
Netwealth Investments Ltd.as of 30 Sep 20251.71m0.44%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025690.39k0.18%
More ▼
Data from 30 Jun 2024 - 04 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.